Perspectives on mesenchymal stem/progenitor cells and their derivates as potential therapies for lung damage caused by COVID-19
Author:
Publisher
Baishideng Publishing Group Inc.
Subject
Cell Biology,Genetics(clinical),Genetics,Molecular Biology,Histology
Reference59 articles.
1. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
2. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths
3. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
4. Clinical Characteristics of Coronavirus Disease 2019 in China
5. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mesenchymal Stem Cells Therapy for COVID-19: From Basic Research to Clinical Trial;Current Stem Cell Research & Therapy;2024-01
2. The role of intensive care nurses in cellular treatments during the COVID‐19 pandemic;Nursing in Critical Care;2023-10-31
3. Key Role of Mesenchymal Stromal Cell Interaction with Macrophages in Promoting Repair of Lung Injury;International Journal of Molecular Sciences;2023-02-08
4. Mesenchymal Stem Cell Secretome for Lung Fibrosis Post Covid-19 Infection-Case Report;Proceedings of The 13th Annual Scientific Conference of Medical Faculty, Universitas Jenderal Achmad Yani (ASCMF 2022);2022-12-16
5. Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19;Cells;2022-07-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3